PICCOLO: An open-label, single arm, phase 2 study of mirvetuximab soravtansine in recurrent platinum sensitive, high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancers with high folate-alpha (FRα) expression (300). - Secord, Angeles Alvarez; Lewin, Sharyn; Murphy, Conleth; Method, Michael (Gynecologic Oncology, 2022)